Eupraxia Pharmaceuticals Inc.
EPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26 | -$29 | -$19 | -$18 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $1 | $1 | $0 |
| Change in WC | -$7 | $5 | $2 | -$0 |
| Other Non-Cash | -$1 | $1 | $1 | $7 |
| Operating Cash Flow | -$30 | -$21 | -$14 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$3 | -$7 |
| Inv. Sales/Matur. | $0 | $0 | $13 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$4 |
| Investing Cash Flow | -$0 | -$0 | $10 | -$11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9 | -$0 | -$0 | $10 |
| Stock Issued | $55 | $16 | $11 | $30 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $5 | $0 | -$0 |
| Financing Cash Flow | $46 | $21 | $11 | $39 |
| Forex Effect | -$2 | $1 | -$1 | -$0 |
| Net Chg. in Cash | $14 | $1 | $6 | $16 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19 | $18 | $13 | $0 |
| End Cash | $33 | $19 | $18 | $17 |
| Free Cash Flow | -$30 | -$21 | -$15 | -$12 |